Problem

AutogenAI addresses the slow, manual, and high-stakes work involved in producing bids, tenders, requests for proposals, and grant applications. Proposal teams must find relevant evidence, interpret complex requirements, preserve compliance, and produce persuasive answers under tight deadlines; the cost is not only staff time but also missed opportunities and lower win rates. The company cites 85% productivity gains, a 70% reduction in drafting time, and a 22% higher win rate among users, while independent research it references found 12.4% revenue growth for AutogenAI users compared with a 7.1% decline among comparable non-users.

The clearest use case is a complex, high-value procurement response with little time to spare—for example, responding to a seven-figure NHS framework with only 48 hours remaining. AutogenAI says its tools can locate evidence from previous projects and compliance policies and produce a high-quality draft in under 30 minutes, turning proposal production from a days-long bottleneck into a faster, more repeatable revenue process.

Product / Service

AutogenAI provides enterprise AI proposal-writing software built around custom language engines trained or configured for an organization’s own knowledge, terminology, and brand voice. Its platform supports bid, proposal, tender, and grant writing, with solutions spanning enterprise teams, grant writers, and federal contractors. The federal product extends across the business-development lifecycle from capture strategy through compliant submission and is positioned for regulated environments with FedRAMP High authorization.

Its differentiator is an agentic Research Assistant rather than a generic chatbot. Given a goal, the system can formulate and refine queries, run multiple searches, scan and interrogate documents, and decide when it has found sufficient evidence. That research is then used to create cleaner, evidence-backed drafts and support review, compliance, and strategic proposal work. The intended benefit is higher throughput and quality while retaining organizational knowledge and security controls; AutogenAI says its institutional knowledge compounds across pursuits and that the platform is designed to help teams win more work.

Market

AutogenAI competes in the emerging AI proposal-writing and broader RFP, bid, tender, response-management, and grant-writing software market. Its competitive set includes established proposal and response platforms such as Responsive, formerly RFPIO, Loopio, PandaDoc, and Proposify. The company positions itself against generic AI tools and narrower response-management products by emphasizing deep research, evidence governance, compliance automation, full-lifecycle workflow coverage, proposal quality, and support for regulated customers.

The company is not pre-revenue or merely at pilot stage based on the available evidence. In January 2026, AutogenAI said it supported more than 250 enterprise customers across the UK, US, and APAC, including Fortune 500 companies, government agencies, consultancies, construction companies, charities, and nonprofits; it also said more than half of the UK Government’s Strategic Suppliers use the platform. Its commercial traction is reinforced by a $39.5 million Series B announced in December 2023, bringing reported total investment to $65.3 million.